SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

DE LA FUENTE, L. et al. Evolución de la necesidad y cobertura de los programas de tratamiento con sustitutivos opioides e intercambio de jeringas en las prisiones españolas, 1992-2009. Rev. esp. sanid. penit. [online]. 2012, vol.14, n.2, pp.37-47. ISSN 1575-0620.

    1. De la Fuente L, Barrio G, Vicente J, Bravo MJ, Lardelli P. Intravenous administration among heroin users having treatment in Spain. Int J Epidemiol.1994; 23: 805-11. [ Links ]

    2. Sánchez-Niubo A, Fortiana J, Barrio G, Suelves JM, Correa JF, Domingo-Salvany A. Problematic heroin use incidence trends in Spain. Addiction. 2009; 104: 248-55. [ Links ]

    3. Castilla J, de la Fuente L. Evolución del número de personas infectadas por el virus de la inmunodeficiencia humana y de los casos de sida en España: 1980-1998. Med Clin (Barc). 2000; 115: 85-9. [ Links ]

    4. de la Fuente L, Brugal MT, Domingo-Salvany A, Bravo MJ, Neira-León M, Barrio G. Más de treinta años de drogas ilegales en España: una amarga historia con algunos consejos para el futuro. Rev Esp Salud Pública. 2006; 80: 505-20. [ Links ]

    5. Jurgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009; 9: 57-66. [ Links ]

    6. Arroyo-Cobo JM. Public health gains from health in prisons in Spain. Public Health. 2010; 124: 629-31. [ Links ]

    7. World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organization; 2009. [ Links ]

    8. Martín-Sánchez M. Programa de prevención y control de enfermedades transmisibles en Instituciones Penitenciarias. Revista de Estudios Penitenciarios Monográfico de Sanidad Penitenciaria. 1990; Extra-1: 51-67. [ Links ]

    9. Shapshak P, McCoy CB, Shah SM, Page JB, Rivers JE, Weatherby NL, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J Acquir Immune Defic Syndr. 1994; 7: 754-9. [ Links ]

    10. Gleghorn AA, Doherty MC, Vlahov D, Celentano DD, Jones TS. Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr. 1994; 7: 767-72. [ Links ]

    11. Barrios Flores LF. Origen y modelos de Programa de Intercambio de Jeringuillas (PIJ) en prisión.Rev Esp Sanid Penit. 2003; 5: 21-9. [ Links ]

    12. Subdirección General de Sanidad Penitenciaria. Intercambio de jeringuillas en el medio penitenciario. Programa Marco. Madrid: Ministerio del Interior y Ministerio de Sanidad y Consumo; 2003. [ Links ]

    13. Hernández-Fernández T, Arroyo-Cobo JM. Results of the Spanish experience: A comprehensive approach to HIV and HCV in prisons. Rev Esp Sanid Penit. 2010; 12: 86-90. [ Links ]

    14. European Monitoring Centre for Drugs and Drug Addiction. Harm reduction: evidence, impacts and challenges. Luxembourg: EMCDDA; 2011. [ Links ]

    15. Vlahov D, Des J, Goosby E, Hollinger PC, Lurie PG, Shriver MD, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001; 154: S70-S77. [ Links ]

    16. Población reclusa [Internet]. Madrid: Instituto Nacional de Estadística; 2011 [actualizado 23 aug 2011; citado 16 nov 2011]. INE; [aprox. 1 pantalla]. Disponible en: http://www.ine.es/inebmenu/mnu_justicia.htm. [ Links ]

    17. Informe General 2009. Secretaria General de Instituciones Penitenciarias [Internet]. Madrid: Ministerio del Interior; 2011 [citado 22 dic 2011]. Disponible en: http://www.institucionpenitenciaria.es/web/export/sites/default/datos/descargables/publicaciones/Informe_General_2009.pdf. [ Links ]

    18. Delegación del Gobierno para el Plan Nacional sobre Drogas. Evaluación terapéutica del drogodependiente que ingresa en prisión. Madrid: Ministerio del Interior; 1994. [ Links ]

    19. Delegación del Gobierno para el Plan Nacional sobre Drogas. Estudio sobre Drogodependientes que ingresan en prisión: Consumo y prácticas de riesgo. Madrid: Ministerio del Interior; 2000. [ Links ]

    20. Oñorbe J, Silvosa G, coord. Encuesta Estatal sobre Salud y Drogas entre los Internados en Prisión (ESDIP) [Internet]. Madrid: Ministerio de Sanidad y Consumo, 2007 (citado: 15 nov 2009). Disponible en: http://www.pnsd.msc.es/Categoria2/publica/pdf/encuestaPenitenciaria2006.pdf. [ Links ]

    21. Statistical bulletin 2011. Drug users in prison [Internet]. Lisboa: European Monitoring Centre for Drugs and Drug Addiction; 2004 [actualizado 04 nov 2011; citado 16 nov 2011]. Disponible en: http://www.emcdda.europa.eu/stats11. [ Links ]

    22. de la Fuente L, Bravo MJ, Barrio G, Parras F, Suárez M, Rodes A, et al. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. Clin Infect Dis. 2003; 37: S410-S415. [ Links ]

    23. Barrio G, Bravo MJ, Brugal MT, Díez M, Regidor E, Belza M, et al. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. Addiction [Internet] 2012 Jun [citado 2012 Jun 5]; 107 (6): 1111-22. doi: 10.1111/j.1360-0443.2011.03759.x. [ Links ]

    24. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010; 376: 285-301. [ Links ]

    25. World Health Organization. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention [Internet]. Geneva: World Health Organization; 2004. [citado 04 nov 2011] Disponible en: http://www.who.int/substance_abuse/publications/treatment/en/index.html. [ Links ]

    26. World Health Organization. Effectiveness of Sterile Needle and Syringe Programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2004. [ Links ]

    27. van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007; 102: 1454-62. [ Links ]

    28. Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010; 100: 1449-53. [ Links ]

    29. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007; 89: 214-22. [ Links ]

    30. Larney S. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction. 2010; 105: 216-23. [ Links ]

    31. García Villanueva M. Programa de Intercambio de Jeringuillas en el Centro Penitenciario de Pamplona. Rev Esp Sanid Penit. 2002; 4: 18-23. [ Links ]

    32. Menoyo C, Zulaica D, Parras F. Needle exchange programs in prisons in Spain. Can HIV AIDS Policy Law Rev. 2000; 5: 20-1. [ Links ]

    33. Bravo MJ, Royuela L, Barrio G, de la Fuente L, Suárez M, Brugal MT. More free syringes, fewer drug injectors in the case of Spain. Soc Sci Med. 2007; 65: 1773-8. [ Links ]